Encysive Pharmaceuticals, Inc. (NASDAQ:ENCY.DL)

CAPS Rating: No stars

A global biopharmaceutical company that engages in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs.

Featured Broker Partners


Advertisement